1. Home
  2. NGVT vs IMCR Comparison

NGVT vs IMCR Comparison

Compare NGVT & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • IMCR
  • Stock Information
  • Founded
  • NGVT 1964
  • IMCR 2008
  • Country
  • NGVT United States
  • IMCR United Kingdom
  • Employees
  • NGVT N/A
  • IMCR N/A
  • Industry
  • NGVT Major Chemicals
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NGVT Industrials
  • IMCR Health Care
  • Exchange
  • NGVT Nasdaq
  • IMCR Nasdaq
  • Market Cap
  • NGVT 1.7B
  • IMCR 1.5B
  • IPO Year
  • NGVT N/A
  • IMCR 2021
  • Fundamental
  • Price
  • NGVT $47.72
  • IMCR $30.00
  • Analyst Decision
  • NGVT Buy
  • IMCR Buy
  • Analyst Count
  • NGVT 5
  • IMCR 13
  • Target Price
  • NGVT $51.00
  • IMCR $65.18
  • AVG Volume (30 Days)
  • NGVT 243.3K
  • IMCR 298.2K
  • Earning Date
  • NGVT 02-18-2025
  • IMCR 02-26-2025
  • Dividend Yield
  • NGVT N/A
  • IMCR N/A
  • EPS Growth
  • NGVT N/A
  • IMCR N/A
  • EPS
  • NGVT N/A
  • IMCR N/A
  • Revenue
  • NGVT $1,479,300,000.00
  • IMCR $296,312,000.00
  • Revenue This Year
  • NGVT N/A
  • IMCR $28.91
  • Revenue Next Year
  • NGVT $2.43
  • IMCR $12.65
  • P/E Ratio
  • NGVT N/A
  • IMCR N/A
  • Revenue Growth
  • NGVT N/A
  • IMCR 25.09
  • 52 Week Low
  • NGVT $30.90
  • IMCR $27.69
  • 52 Week High
  • NGVT $56.30
  • IMCR $76.98
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 68.63
  • IMCR 50.53
  • Support Level
  • NGVT $36.25
  • IMCR $28.22
  • Resistance Level
  • NGVT $40.82
  • IMCR $30.77
  • Average True Range (ATR)
  • NGVT 1.71
  • IMCR 1.35
  • MACD
  • NGVT 1.08
  • IMCR 0.08
  • Stochastic Oscillator
  • NGVT 96.43
  • IMCR 51.90

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.

Share on Social Networks: